Risk factors for endometrial hyperplasia concomitant endometrial polyps in pre- and post-menopausal women

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 13, 2014, Pages 5423-5425

  Topcu, Hasan Onur ^a   Erkaya, Salim ^a   Guzel, Ali Irfan ^a   Kokanali, Mahmut Kuntay ^a   Sarikaya, Esma ^a   Muftuoglu, Kamil Hakan ^b   Doganay, Melike ^a  

^a Obstetrics and Gynecology Medicine   (Turkey)

^b ZEKAI TAHIR BURAK WOMEN S HEALTH EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Concomitant presence; Endometrial hyperplaisa; Endometrial polyps; Risk factors

Indexed keywords

ADULT; AGED; BODY MASS; DIABETES MELLITUS; ENDOMETRIAL HYPERPLASIA; FEMALE; HUMAN; HYSTERECTOMY; MENOPAUSE; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; POLYPS; POSTMENOPAUSE; PREMENOPAUSE; PROCEDURES; RETROSPECTIVE STUDY; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; DIABETES MELLITUS; ENDOMETRIAL HYPERPLASIA; FEMALE; HUMANS; HYSTERECTOMY; MENOPAUSE; MIDDLE AGED; POLYPS; POSTMENOPAUSE; PREMENOPAUSE; RETROSPECTIVE STUDIES; RISK FACTORS; WOMEN;

EID: 84905392333     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.13.5423     Document Type: Article

References (14)

1. Acmaz G, Aksoy H, Albayrak E, et al (2014). Evaluation of endometrial precancerous lesions in postmenopausal obese women-a high riskgroup? Asian Pac J Cancer Prev, 15, 195-198.
2. Balik G, Kagitci M, Ustuner I, et al (2013). Which endometrial pathologies need intraoperative frozen sections? Asian Pac J Cancer Prev, 14, 6121-6125.
3. Costa-Paiva L, Godoy CE Jr, Antunes A Jr, et al (2011). Risk of malignancy in endometrial polyps in premenopausal andpostmenopausal women according to clinicopathologic characteristics. Menopause, 18, 1278-82.
4. de Carvalho S, Campaner AB, Lima SM, et al (2011). Differential expression of estrogen and progesterone receptors in endometrial polyps andadjacent endometrium in postmenopausal women. Anal Quant Cytol Histol, 33, 61-67.
5. Hileeto D, Fadare O, Martel M, et al (2005). Age dependent association of endometrial polyps with increased risk of cancer involvement. World J Surg Oncol, 9, 8.
6. Giordano G, Gnetti L, Merisio C, et al (2007). Postmenopausal status, hypertension and obesity as risk factors for malignant transformationin endometrial polyps. Maturitas, 20, 190-7.
7. Karimi Zarchi M, Behtash N, Sekhavat L, et al (2009). Effects of tamoxifen on the cervix and uterus in women with breast cancer: experience with Iranian patients and a literature review. Asian Pac J Cancer Prev, 10, 595-8.
8. Kim MK, Seong SJ (2013). LNG-IUS treatment of non-atypical endometrial hyperplasia: Can Pipelle endometrial samplingbe an accurate method of follow-up evaluation? J Gynecol Oncol, 24, 103-4.
9. Kleebkaow P, Maneetab S, Somboonporn W, et al (2008). Preoperative and postoperative agreement of histopathological findings incases of endometrial hyperplasia. Asian Pac J Cancer Prev, 9, 89-91.
10. Lenci MA, do Nascimento VA, Grandini AB, et al (2014). Premalignant and malignant lesions in endometrial polyps in patients undergoing hysteroscopic polypectomy. Einstein (Sao Paulo), 12, 16-21.
11. Li XC, Song WJ (2013). Endometrial intraepithelial neoplasia (EIN) in endometrial biopsy specimens categorized by the1994 World Health Organization classification for endometrial hyperplasia. Asian Pac J Cancer Prev, 14, 5935-9.
12. Munro MG, Critchley HO, Broder MS, et al (2011). FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet, 113, 3-13.
13. Nicholson WK, Ellison SA, Grason H, et al (2001). Patterns of ambulatory care use for gynecologic conditions: A national study. Am J Obstet Gynecol, 184, 523-530.
14. Salim S, Won H, Nesbitt-Hawes E, et al (2011). Diagnosis and management of endometrial polyps: a critical review of the literature. J Minim Invasive Gynecol, 18, 569-81.